MPO and periodontal disorder: In fact, it was intriguing to observe a reduction in the MPO levels also in rats treated with morphine, since it was previously shown that the opioid agonist was unable to affect the increased cell number in ligated sites, although it decreased other indicators of periodontal disease like bone and attachment loss, as shown here and in [11].